Location: Home
  • search
  • go
  • Relate News
  • 5/3/2022International Cooperation Under China's Proposed Implementing Rules Fo...
  • 5/3/2022Navigating The Latest Changes In China's Regulation Of Human Genetic R...
  • 5/2/2022China in Lockdown Mode … Are Long Term Prospects and Bright Spots Sti...
  • 5/2/2022China Continues to Drop Reimbursements via DIP system: PBM
  • 5/2/2022U.S. FDA Snubs Two More China Only-Tested New Drugs from Hutchmed and ...
  • 5/2/2022Merck's MilliporeSigma Invests €100M to Accelerate Single-Use Manufac...
  • 5/2/2022Former GSK Scientist Convicted of Stealing Trade Secrets To Benefit Ch...
  • 5/2/2022Pfizer Wins Chinese Approval of lorlatinib for ALK-positive Advanced N...
  • 4/29/2022Novartis Reports Performance in Q1/2022 with China Business Up 16%
  • 4/29/2022CDE Seeks Participation for Questionnaire Survey on Pediatric Drug R&D...
  • 4/29/2022BMS and Chinese Partner LianBio Won FDA Nod for Camzyos to Treat Hea...
  • 4/29/2022NHSA and NHC Issue Notice to Improve National 6th VBP (Insulin Program...
  • 4/29/2022Recent Executive Moves
  • 4/29/2022Drug R&D and Product Registration News Digest April 2022 (4)
  • 4/29/2022Financial-related Company News Digest
  • 4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)
  • 4/28/2022The Three Key Drivers That Are Shaping China's Cell and Gene Therapy I...
  • 4/28/2022Biotech Venture Capital Investment in China Climbs (WSJ)
  • 4/28/2022NMPA Holds Meeting to Review Vaccine Regulatory Quality Management Sys...
  • 4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...
  • 4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...
  • 4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022
  • 4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China
  • 4/27/2022Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
  • 4/27/2022Lupin Inks Pact with Yabao to Market Pediatric Formulations in China
  • 4/27/2022China Biotech CEO Podcast: CANbridge's Xue On Orphan Drug Coverage, Fi...
  • 4/27/2022More Than Half of IBD Patients in China Have Poor Response to Anti-TNF...
  • 4/27/2022Significant Increase in Diabetes Prevalence Observed in China
  • 4/26/2022China Clears Homegrown PD-1 Inhibitors for Solid Tumors (PharmaDJ's Ch...
  • 4/26/2022Arrowhead and Vivo Capital Launch JV Aimed at Greater China Market
  • Page:142/775 Total number of articles:23235: [First][<<] [140] [141] [142] [143] [144] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group